If you are considering taking part in a clinical trial at ALYATEC, you will find below the list of ongoing studies:
PALPEBRAL Study: Atopic Dermatitis
Who is eligible? Adults experiencing symptoms of atopic dermatitis affecting the face and/or neck, whether or not they are treated with topical corticosteroids.
What is the purpose of the study? To demonstrate the tolerance and effectiveness of the dermocosmetic product Palpebral Balm in reducing symptoms of mild to moderate atopic dermatitis.
When? Participant inclusion from January 27 to April 26, 2026.
Additional information? Compensation of €40 per visit. Between 3 and 4 visits, each lasting no more than one hour, to be carried out at ALYATEC over a period of 4 to 8 weeks.
>> More information by clicking here <<
DIA-001 Study: Cat Allergy
Who is eligible? Adults with allergic conjunctivitis caused by cat allergens.
What is the purpose of the study? To detect the presence of biomarkers specific to cat allergy in the tear fluid of patients with allergic conjunctivitis.
When? Study conducted between February and May 2026.
Additional information? Compensation ranging from €80 to €120, depending on the number of biological sample collections. Two to three appointments at ALYATEC, to be completed within a maximum of two days.
>> More information by clicking here <<
Upcoming clinical studies
Additional clinical studies will be starting soon at ALYATEC, particularly in the areas of atopic dermatitis (eczema), food allergies (peanuts, hazelnuts, walnuts, sesame, fish, soy, egg, wheat, etc.), and for adolescents allergic to birch pollen (ages 12–17).
Please feel free to contact us to schedule an appointment and register in our volunteer database.
You may also refer friends or family members to participate in a study and earn €50 through our referral program.